{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:58:41Z","timestamp":1785279521407,"version":"3.55.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sepsis-induced acute lung injury (ALI) is a severe complication characterized by uncontrolled inflammation and high mortality, yet effective targeted therapies remain limited. Notably, acute myocardial infarction (MI) frequently coexists with or exacerbates ALI through shared inflammatory pathways. Dexamethasone (Dex) exerts potent anti-inflammatory effects but its clinical application is limited by non-specific biodistribution and dose-dependent off-target toxicities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We developed a biomimetic nanoplatform Dex@mPLGA by coating dexamethasone-loaded poly (lactic-co-glycolic acid) (PLGA) nanoparticles with RAW264.7 macrophage membranes. The physicochemical properties of Dex@mPLGA were systematically characterized. Cellular uptake, cytotoxicity, anti-inflammatory, antioxidant, anti-apoptotic, and immunomodulatory effects were evaluated in LPS-stimulated RAW264.7 cells.\n                      <jats:italic>In vivo<\/jats:italic>\n                      biodistribution, therapeutic efficacy, and biosafety were further evaluated in an LPS-induced ALI mouse model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Dex@mPLGA exhibited a core\u2013shell structure with an average particle size of 147.3 nm, negative surface charge, 3.2% drug loading, 74.6% encapsulation efficiency, good colloidal stability, and sustained Dex release. SDS-PAGE analysis supported the retention of macrophage membrane protein components in the final formulation. Dex@mPLGA was internalized by RAW264.7 macrophages in a time-dependent manner and showed minimal cytotoxicity at the tested concentrations. In LPS-stimulated macrophages, Dex@mPLGA alleviated inflammatory and oxidative stress-related responses relative to the LPS model, including improved cell viability, reduced ROS and MDA levels, decreased pro-inflammatory cytokine and NO production, increased IL-10 secretion, reduced apoptosis, restored proliferative activity, and modulation of macrophage polarization. Direct comparison with uncoated Dex@PLGA showed that the additional\n                      <jats:italic>in vitro<\/jats:italic>\n                      benefit of macrophage membrane coating was endpoint-dependent rather than universal. Statistically significant coating-associated improvements were mainly observed in cell viability, IL-10 secretion, EdU-positive proliferative recovery, and M2 polarization, whereas several inflammatory, oxidative stress-related, apoptotic, and M1-polarization readouts were comparable between Dex@PLGA and Dex@mPLGA.\n                      <jats:italic>In vivo<\/jats:italic>\n                      , Dex@mPLGA showed improved pulmonary accumulation in inflamed lung tissues, improved survival outcomes, reduced systemic pro-inflammatory cytokine levels, and alleviated lung histopathological injury. Short-term biosafety evaluation showed no obvious organ toxicity or abnormal serum biochemical changes under the tested conditions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Dex@mPLGA represents an innovative biomimetic Dex delivery platform with therapeutic potential for sepsis-induced ALI. Its efficacy is likely associated with PLGA-mediated sustained Dex delivery, macrophage-associated uptake, selected membrane-related immunoregulatory benefits, and improved pulmonary accumulation\n                      <jats:italic>in vivo<\/jats:italic>\n                      . However, the incremental\n                      <jats:italic>in vitro<\/jats:italic>\n                      advantage of Dex@mPLGA over Dex@PLGA was modest and endpoint-dependent, and the membrane coating should be interpreted as providing selected auxiliary benefits rather than uniformly enhancing all biological outcomes. Further studies are needed to validate membrane-specific targeting and long-term safety in more physiologically relevant models.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1857409","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:10:19Z","timestamp":1785276619000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Biomimetic dexamethasone-loaded nanoparticles attenuate sepsis-induced acute lung injury"],"prefix":"10.3389","volume":"17","author":[{"given":"LiuGuang","family":"Song","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine","place":["Hangzhou, China"]},{"name":"State Key Laboratory of Transvascular Implantation Devices","place":["Hangzhou, China"]},{"name":"Heart Regeneration and Repair Key Laboratory of Zhejiang Province","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZheChu","family":"Xuan","sequence":"additional","affiliation":[{"name":"School of Medicine and Nursing, Huzhou University","place":["Huzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChunNa","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine","place":["Hangzhou, China"]},{"name":"State Key Laboratory of Transvascular Implantation Devices","place":["Hangzhou, China"]},{"name":"Heart Regeneration and Repair Key Laboratory of Zhejiang Province","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiangLiang","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine","place":["Hangzhou, China"]},{"name":"State Key Laboratory of Transvascular Implantation Devices","place":["Hangzhou, China"]},{"name":"Heart Regeneration and Repair Key Laboratory of Zhejiang Province","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zheng","sequence":"additional","affiliation":[{"name":"School of Medicine and Nursing, Huzhou University","place":["Huzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuMeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Zhejiang Provincial People\u2019s Hospital, Affiliated People\u2019s Hospital, Hangzhou Medical College","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhengMing","family":"Wu","sequence":"additional","affiliation":[{"name":"The Third People\u2019s Hospital of Deqing, Deqing Hospital of Hangzhou Normal University","place":["Deqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital, Zhejiang University School of Medicine","place":["Hangzhou, China"]},{"name":"State Key Laboratory of Transvascular Implantation Devices","place":["Hangzhou, China"]},{"name":"Heart Regeneration and Repair Key Laboratory of Zhejiang Province","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Liang","sequence":"additional","affiliation":[{"name":"Laboratory Department, The Second Hospital of Jiaxing","place":["Jiaxing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1874467215666220324114624","article-title":"Immunomodulatory therapeutic effects of curcumin on M1\/M2 macrophage polarization in inflammatory diseases","volume":"16","author":"Abdollahi","year":"2023","journal-title":"Curr. Molecular Pharmacology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42247-023-00453-8","article-title":"Implications of biomimetic nanocarriers in targeted drug delivery","volume":"6","author":"Al-Hetty","year":"2023","journal-title":"Emergent Mater."},{"key":"B3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41420-023-01766-7","article-title":"Immune dysregulation in sepsis: experiences, lessons and perspectives","volume":"9","author":"Cao","year":"2023","journal-title":"Cell Death Discovery"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6260","DOI":"10.1097\/JS9.0000000000002668","article-title":"Unveiling the research advances of sepsis: pathogenesis, precise intervention and clinical perspective","volume":"111","author":"Cheng","year":"2025","journal-title":"Int. J. Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3390\/biom15111609","article-title":"Lactobacilli-Derived microbe-associated molecular patterns (MAMPs) in host immune modulation","volume":"15","author":"Furnari","year":"2025","journal-title":"Biomolecules"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S0140-6736(22)01439-8","article-title":"Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management","volume":"400","author":"Gorman","year":"2022","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"101638","DOI":"10.1016\/j.redox.2020.101638","article-title":"Targeting NOX4 alleviates sepsis-induced acute lung injury via attenuation of redox-sensitive activation of CaMKII\/ERK1\/2\/MLCK and endothelial cell barrier dysfunction","volume":"36","author":"Jiang","year":"2020","journal-title":"Redox Biology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.actbio.2022.11.059","article-title":"Biomimetic camouflaged nanoparticles with selective cellular internalization and migration competences","volume":"157","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2023","journal-title":"Acta Biomater."},{"key":"B9","first-page":"3","volume-title":"History, Introduction, and Properties of PLGA as a Drug Delivery carrier Poly (lactic-co-glycolic Acid)(Plga) Nanoparticles for Drug Delivery","author":"K\u0131r\u0131ml\u0131o\u011flu","year":"2023"},{"key":"B10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/epidemiologia5030032","article-title":"The global burden of sepsis and septic shock","volume":"5","author":"La Via","year":"2024","journal-title":"Epidemiologia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6362344","DOI":"10.1155\/2022\/6362344","article-title":"Classic signaling pathways in alveolar injury and repair involved in sepsis\u2010induced ALI\/ARDS: new research progress and prospect","volume":"2022","author":"Li","year":"2022","journal-title":"Dis. Markers"},{"key":"B12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13020-025-01067-4","article-title":"The role of natural products targeting macrophage polarization in sepsis-induced lung injury","volume":"20","author":"Li","year":"2025","journal-title":"Chin. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1415274","DOI":"10.3389\/fmicb.2024.1415274","article-title":"From immune dysregulation to organ dysfunction: understanding the enigma of Sepsis","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1021\/acsbiomaterials.2c00026","article-title":"Dexamethasone: insights into pharmacological aspects, therapeutic mechanisms, and delivery systems","volume":"8","author":"Madamsetty","year":"2022","journal-title":"ACS Biomaterials Science and Engineering"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3390\/pharmaceutics15061772","article-title":"Use of poly lactic-co-glycolic acid nano and micro particles in the delivery of drugs modulating different phases of inflammation","volume":"15","author":"Puricelli","year":"2023","journal-title":"Pharmaceutics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12964-024-01620-y","article-title":"Endothelial cell dynamics in sepsis-induced acute lung injury and acute respiratory distress syndrome: pathogenesis and therapeutic implications","volume":"22","author":"Qiao","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"B17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.it.2023.10.004","article-title":"Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis","volume":"44","author":"Rodr\u00edguez-Morales","year":"2023","journal-title":"Trends Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/biomimetics8070543","article-title":"Biomimetic systems involving macrophages and their potential for targeted drug delivery","volume":"8","author":"Savchenko","year":"2023","journal-title":"Biomimetics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1289194","DOI":"10.3389\/fmed.2023.1289194","article-title":"Acute lung injury caused by sepsis: how does it happen?","volume":"10","author":"Sun","year":"2023","journal-title":"Front. Medicine"},{"key":"B20","doi-asserted-by":"publisher","first-page":"870239","DOI":"10.3389\/fimmu.2022.870239","article-title":"Reactive oxygen species induce fatty liver and ischemia-reperfusion injury by promoting inflammation and cell death","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1209438","DOI":"10.3389\/fimmu.2023.1209438","article-title":"The role of macrophages polarization in sepsis-induced acute lung injury","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"155591","DOI":"10.1016\/j.phymed.2024.155591","article-title":"Syringic acid attenuates acute lung injury by modulating macrophage polarization in LPS-Induced mice","volume":"129","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"13499","DOI":"10.2147\/IJN.S546817","article-title":"Macrophage membrane-coated nanocarriers in myocardial infarction: a paradigm shift in targeted cardiac therapy","volume":"20","author":"Wang","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e08761","DOI":"10.1002\/adfm.202508761","article-title":"Biomaterial strategies for targeted intracellular delivery to phagocytes","volume":"36","author":"Woodworth","year":"2026","journal-title":"Adv. Funct. Mater."},{"key":"B25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s12951-022-01746-6","article-title":"Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment","volume":"20","author":"Wu","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/1061186X.2022.2071426","article-title":"Macrophage membrane biomimetic drug delivery system: for inflammation targeted therapy","volume":"31","author":"Zhang","year":"2023","journal-title":"J. Drug Target."},{"key":"B27","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.21037\/jtd-24-1191","article-title":"Early identification and diagnosis, pathophysiology, and treatment of sepsis-related acute lung injury: a narrative review","volume":"16","author":"Zhang","year":"","journal-title":"J. Thorac. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"9659","DOI":"10.2147\/IJN.S479212","article-title":"Novel strategies for tumor treatment: harnessing ROS-Inducing active ingredients from traditional chinese medicine through multifunctional nanoformulations","volume":"19","author":"Zhang","year":"","journal-title":"Int. Journal Nanomedicine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"22279","DOI":"10.1021\/acsami.4c22304","article-title":"Exosomes derived from bone marrow mesenchymal stem cells encapsulated in M2 macrophage cell membrane targeted to inhibit joint periprosthetic inflammation","volume":"17","author":"Zhang","year":"2025","journal-title":"ACS Appl. Mater. and Interfaces"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacasi.2026.02.013","article-title":"The postnatal lung maturation disrupted by increased pulmonary blood flow and its clinical implications","author":"Zheng","year":"2026","journal-title":"JACC Asia"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1857409\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:10:20Z","timestamp":1785276620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1857409\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":30,"alternative-id":["10.3389\/fphar.2026.1857409"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1857409","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"article-number":"1857409"}}